caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1174506752

Maria CicchettiM.D.

Radiation OncologyWorcester, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 220012
Hospital
CCN 220135
Hospital
CCN 220162
Hospital
CCN 221300
Hospital
REFERRAL NETWORK

Where Maria Cicchetti's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SHARENOW, ELLEN2226
Madhavi Toke
Hematology-Oncology · Worcester, MA
15145
Dina Kandil
Pathology · Worcester, MA
1426
Gopal Vijayaraghavan
Diagnostic Radiology · Worcester, MA
1123
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
UMASS MEMORIAL MEDICAL CENTER, INC.72919
Anne Larkin
General Surgery · Worcester, MA
1677
Kathryn Edmiston
Hematology-Oncology · Worcester, MA
1460
James Liebmann
Hematology-Oncology · Worcester, MA
1345
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
1240
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
984
Unique beneficiaries
—
Total services
2,737
Distinct HCPCS
18
Medicare payment
$181K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 172 Radiation Oncology providers in MA — top quintile (cohort median 1,439).
PRESCRIBING · PART D · 2024
Total Rx claims
55
Beneficiaries
—
Total drug cost
$750
Distinct drugs
2
Brand share
43.6%
Top prescribed drugs
Tamsulosin Hcl31 claims
Lidocaine Hcl24 claims
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
71.5
Cost
74.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.